The U-500 strength of Humulin R comes in two forms: 20-mL vials that you’ll use with insulin syringes 3-mL disposable, prefilled injection pens called a KwikPens Note: Humulin R U-100 is ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...

Some pens use cartridges inserted into the pen ... National Institutes of Health. DailyMed. Label: Humulin R U-500- insulin human injection, solution. Humulin R U-500 Kwikpen- insulin human injection, ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

The Galaxy S25 Ultra’s S Pen lacks Bluetooth connectivity and components like a battery. Despite the missing hardware and features, the replacement S Pen costs $50, the same as the previous ...

Samsung has since clarified that Bluetooth support for the S Pen is, in fact, gone. According to Samsung, the blog post was made in error, and the Galaxy S25 Ultra will not offer any Bluetooth ...

ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...